Amylin Pharma’s Diabetes Injection Bags USFDA Nod
Mon, 01/30/2012 - 07:57 | 
After two earlier rejections in 2010, Amylin Pharmaceutical’s diabetes medication Bydureon lastly bagged the Food and Drug Administration’s (FDA) nod on January 27.
Spectrum Pharmaceuticals has inked a deal to get hold of licensing rights to sell ZEVALIN (ibritumomab tiuxetan) jab for intravenous usage outside of the United States from Bayer Healthcare.
Fitch Ratings said that the 2012 viewpoint for the Indian pharmaceutical sector is static. The agency projects credit profiles to stay stable given that long-standing profits and profitability outlooks stay intact with moderate capital expenditure.
Tags: Watson Pharma Bags USFDA Nod For Antares' Oxybutynin Gel; RBI Notifies New FDI Rules For Pharma Section
Watson Pharmaceuticals, a top integrated global pharma firm, and Antares Pharma, Inc have bagged the USFDA nod for Antares' topical oxybutynin gel 3% medicine for treating overactive bladder (OAB).
ZEVALIN is recently sanctioned by the FDA and commercialized by Spectrum Pharmaceuticals in the United States for treating sufferers with previously untreated follicular non-hodgkin lymphoma.
Auxilium Pharmaceuticals Inc. has named Adrian Adams as president and CEO with immediate effect. Adrian succeeds Armando Anido.
